Amniotic Products Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Amniotic Products Market Size

Amniotic Products Market Trends & Drivers

Spike in Incidence of Burn Injuries To Drive Market

The rise in the number of people with burns is a key contributor to the industry growth. This is because of the growing demand for amniotic membranes due to the high prevalence of burn wounds. Additionally, there is significant emotional and physical suffering associated with such mishaps, which, in turn, drives the sector significantly.

With almost 9 million injuries and an estimated 120,000–180,000 deaths per year, such injuries place a considerable burden on the global population. The majority of the burns take place in developing and underdeveloped nations, with over two-thirds in Africa and Southeast Asia.

Amniotic Products Market Analysis

Membranes Category Leads Type Segment

On the basis of type, the membranes category led the market, with 80% share, in 2022. The larger share of this category can be attributable to the membranes' superior effectiveness over suspensions. The sector is expected to expand at an exponential rate due to the rising usage of such membranes for a variety of ophthalmic problems, including ocular surface lesions, such as indolent ulcers, as well as for corneal limbal stem cell deficiency and retinal detachment.

Cryopreserved amniotic membranes have contributed majorly to the market growth as they are frequently used during eye-related procedures to help with healing and minimizing eye inflammation.

Additionally, venous and pressure leg ulcers, as well as a variety of surgical wounds, are treated with dehydrated amniotic membranes. They are typically applied as biological bandages, to aid with healing. Due to their capacity to keep a watertight seal, limit inflammatory reactions, and restrict the spread of disease, these membranes are also commonly utilized in the treatment and care of surgical wounds and incisions. Dehydrated membrane usage is, thus, expected to increase rapidly in the coming years.

The suspensions category is also projected to expand at a steady CAGR, of 7%, in the years to come. The use of amniotic suspensions as a successful non-operative product for symptomatic knee osteoarthritis has increased. Studies on the effectiveness as well as lack of side-effects of such suspensions for symptomatic osteoarthritis are expected to fuel the category’s expansion. For instance, Organogenesis Inc. unveiled ReNu, an amniotic suspension, in July 2021. The firm also received the FDA’s Regenerative Medicine Therapy designation, for its utilization in treating osteoarthritis of the knee.

Surgical Wounds Category Leads Application Segment

The surgical wounds category dominated the application segment, with 60% share, in 2022. This is credited to the rise in the cases of surgical and traumatic wounds, a spike in the number of burn injuries and ulcers, and the increase in the need for innovative technologies to treat them. Furthermore, an increase in the count of surgical procedures has been observed globally as a result of the rise in the incidence of chronic and infectious diseases, which has given the industry lucrative growth potential. Most frequently, these products are employed during ocular procedures to promote quicker healing and lessen inflammation. These membranes are, additionally, used in reconstructive procedures to lower the chances of infection, lessen scarring, and speed up the process of healing.

Thus, the market expansion is being greatly aided by the enormous demand for these items due to the rising number of cosmetic operations. The reconstructive surgical procedures performed on burn patients also utilize these items, to facilitate epithelialization and quick wound healing, which increases the demand for them. It has also reduced discomfort and allowed for simple movements of the injured area. This approach is rapidly being employed in developing countries because it is less expensive than allografts and xenografts.

The rapid growth in the senior population significantly boosts the ophthalmology category, as this demographic is highly prone to ocular disorders. Amniotic products are frequently used to treat conditions affecting the eye's surface, including bacterial keratitis, corneal ulcers, cataracts, glaucoma, bullous keratopathy, corneal degeneration, ocular dystrophy, and eyelid reconstruction. The number of ophthalmic surgeries has increased because of the growing elderly population around the world, which has greatly raised the demand for these tissue-based products.

Regional Analysis

North America Is Largest Revenue Contributor

North America led the sector, with a revenue share of 60%, in 2022. The main contributors to the regional market growth are the presence of top industry competitors and well-established healthcare facilities. During the projection period, the increasing attention being given to alternative technologies is expected to further fuel the sector’s growth in the continent.

In addition, the most-frequently performed surgical procedure in the U.S. is Cesarean delivery. According to studies, amniotic membrane dressing can help avoid the usage of painkillers after a Cesarean section, by effectively reducing post-operative pain.

The second-largest revenue share is held by Europe. The massive public funding for the healthcare system in the European region and the implementation of universal healthcare systems in numerous countries have increased the demand for the product. Moreover, the usage of amniotic membranes by medical practitioners is set to rise as the number of patients with chronic conditions grows.

According to a study, non-infectious diseases are the major causes of death in the European region, accounting for approximately 75% of the annual deaths. Some of the major NCDs prevalent in the region are CVDs, cancer, and diabetes. Therefore, the increase in the count of surgical treatments because of the high frequency of such illnesses will hasten the industry expansion.

Additionally, the demand for these products in Germany is expanding significantly. This is because of the robust growth in the country’s medical budget, the adoption of solutions integrated with advanced technologies, and rising awareness of early disease diagnosis and effective treatment, driven by government efforts. Furthermore, the advantageous reimbursement policies in regional countries are ultimately driving the sector’s growth.

On top of all the above-mentioned factors, it has been observed from recent studies that Germany’s older population has significantly risen over the past few years. In 2021, people aged 65 or above numbered approximately 18 million in the country. The growing need of older people for surgeries, because of their susceptibility to chronic conditions, will further lead to the sector’s expansion.

Market Breakdown

This report offers deep insights into the amniotic products industry, with size estimation for 2019 to 2030, the major drivers, restraints, trends and opportunities, and competitor analysis.

Based on Type

• Membranes
  • Cryopreserved
  • Dehydrated
• Suspensions

Based on Application

• Ophthalmology
• Surgical Wounds
• Orthopedics

Based on End User 

• Hospitals
• ASCs
• Specialty Clinics
• Research and Academic Institutes

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • U.A.E.

Top Amniotic Products Companies